LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 83.72 | 27.76 | 3667 | 7055 | 0.5197 | 0.8427 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 83.72 | 27.76 | 4516 | 7055 | 0.6401 | 0.8914 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 83.72 | 27.76 | 5 | 7055 | 0.0007 | -0.1931 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 83.72 | 27.76 | 5153 | 7055 | 0.7303 | 0.9229 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 85.42 | 27.76 | 3744 | 7025 | 0.5329 | 0.8484 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 85.42 | 27.76 | 3808 | 7025 | 0.5420 | 0.8523 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 85.42 | 27.76 | 3333 | 7025 | 0.4744 | 0.8217 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 85.42 | 27.76 | 4592 | 7025 | 0.6536 | 0.8963 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 85.42 | 27.76 | 4 | 7025 | 0.0006 | -0.2155 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 85.42 | 27.76 | 5235 | 7025 | 0.7451 | 0.9276 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.13 | 27.76 | 3844 | 6987 | 0.5501 | 0.8556 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.13 | 27.76 | 3905 | 6987 | 0.5588 | 0.8593 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.13 | 27.76 | 3480 | 6987 | 0.4980 | 0.8326 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.13 | 27.76 | 4684 | 6987 | 0.6703 | 0.9022 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.13 | 27.76 | 1 | 6987 | 0.0001 | -0.3408 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.13 | 27.76 | 5333 | 6987 | 0.7632 | 0.9334 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.84 | 27.76 | 3916 | 6965 | 0.5622 | 0.8606 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.84 | 27.76 | 3990 | 6965 | 0.5729 | 0.8650 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.84 | 27.76 | 3744 | 6965 | 0.5375 | 0.8502 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.84 | 27.76 | 4807 | 6965 | 0.6902 | 0.9091 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.84 | 27.76 | 1 | 6965 | 0.0001 | -0.3410 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.84 | 27.76 | 5361 | 6965 | 0.7697 | 0.9354 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.55 | 27.76 | 3980 | 6928 | 0.5744 | 0.8655 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.55 | 27.76 | 4052 | 6928 | 0.5848 | 0.8697 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.55 | 27.76 | 3227 | 6928 | 0.4657 | 0.8170 | MN20160318_Q01 | H12 |